China Shineway Pharmaceutical Group Limited (C1S) — Cash Flow-to-Debt Ratio
China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2023, meaning its operating cash flow of €160.69 Million could theoretically repay 0% of its total liabilities (€2.26 Billion) in one year. See financial flexibility index of China Shineway Pharmaceutical Group Limi to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China Shineway Pharmaceutical Group Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for China Shineway Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see cash flow conversion of China Shineway Pharmaceutical Group Limi.
Annual Cash Flow-to-Debt Ratio for China Shineway Pharmaceutical Group Limited (2013–2025)
Year-by-year debt coverage analysis for China Shineway Pharmaceutical Group Limited. Check how high is China Shineway Pharmaceutical Group Limi's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.43x | €1.17 Billion | €2.72 Billion | ▲ +15.4% |
| 2024 | 0.37x | €963.13 Million | €2.57 Billion | ▲ +1.9% |
| 2023 | 0.37x | €932.63 Million | €2.54 Billion | ▼ -38.8% |
| 2022 | 0.60x | €1.11 Billion | €1.85 Billion | ▲ +11.1% |
| 2021 | 0.54x | €703.15 Million | €1.30 Billion | ▲ +20.0% |
| 2020 | 0.45x | €638.57 Million | €1.42 Billion | ▲ +65.6% |
| 2019 | 0.27x | €368.00 Million | €1.35 Billion | ▼ -50.7% |
| 2018 | 0.55x | €532.59 Million | €966.01 Million | ▼ -5.1% |
| 2017 | 0.58x | €490.65 Million | €844.16 Million | ▼ -33.6% |
| 2016 | 0.87x | €733.53 Million | €838.59 Million | ▲ +0.7% |
| 2015 | 0.87x | €744.71 Million | €857.13 Million | ▲ +14.0% |
| 2014 | 0.76x | €773.16 Million | €1.01 Billion | ▲ +91.9% |
| 2013 | 0.40x | €519.89 Million | €1.31 Billion | — |